Data / Form D filings / Therini Bio, Inc.
Therini Bio, Inc.: Form D filings
Therini Bio, Inc., a biotechnology company in Sacramento, CA, filed 4 Form D notices with the SEC between 2019 and 2025. The latest, on September 8, 2025, reports $74.9 million sold of a $80.8 million offering to 17 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2108 N STREET, SUITE 4963, Sacramento, CA, 95816
- Phone
- (818) 414-1105
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1776935
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 8, 2025 | Amendment | $80,781,009 | $74,870,150 | $5,910,859 | 17 | Mar 29, 2023 | sec.gov |
| Apr 14, 2023 | New notice | $54,617,530 | $26,619,532 | $27,997,998 | 8 | Mar 29, 2023 | sec.gov |
| May 22, 2020 | Amendment | $9,356,749 | $9,356,749 | 4 | May 8, 2019 | sec.gov | |
| May 17, 2019 | New notice | $6,499,430 | $2,356,749 | $4,142,681 | 2 | May 8, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Olga D Danilchanka | Director | |
| Laia D Crespo-Martin | Director | |
| Leslie D Schulze | Executive Officer | |
| Daniel D Burgess | Director | |
| Michael D Ross | Director | |
| Laurence Barker | Director | |
| Tara Nickerson | Executive Officer, Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Sep 8, 2025 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Therini Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.